{
    "Trade/Device Name(s)": [
        "AgaMatrix Jazz Wireless 2 Blood Glucose Monitoring System",
        "AgaMatrix Jazz Blood Glucose Test Strips"
    ],
    "Submitter Information": "AgaMatrix, Inc.",
    "510(k) Number": "K152365",
    "Predicate Device Reference 510(k) Number(s)": [
        "K103544"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "April 12, 2016",
    "Summary Letter Received Date": "April 14, 2016",
    "Submission Date": "April 8, 2016",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Glucose oxidase, glucose"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "AgaMatrix Jazz Wireless 2 Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric method",
        "Dynamic electrochemistry",
        "Glucose oxidase (GO) enzymatic reaction"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip"
    ],
    "Document Summary": "FDA 510(k) summary for AgaMatrix Jazz Wireless 2 Blood Glucose Monitoring System for self-monitoring blood glucose using capillary whole blood from fingertip.",
    "Indications for Use Summary": "Quantitative measurement of blood glucose in fresh capillary whole blood from the fingertip, for self-testing by individuals with diabetes at home as an aid to monitor effectiveness of diabetes control; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}